The Harvard Drug Group is recalling four cartons of Carbamazepine 200mg Tablets (generic Tegretol) due to a failure in dissolution specifications. This means the medication may not dissolve properly in the body, which can prevent the patient from receiving the intended dose of the medicine. These prescription tablets were manufactured by Torrent Pharmaceuticals and distributed in 100-count unit dose cartons. Consumers should contact their healthcare provider or pharmacist immediately to discuss alternative treatments and how to return the affected product.
If the tablets do not dissolve at the required rate, the medication may not be absorbed effectively, potentially leading to lower-than-expected blood levels of the drug. This could result in a loss of seizure control or a decrease in the effectiveness of the treatment for the underlying condition.
Healthcare consultation and product return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.